Security key
126638105
CVRx, Inc. - Common Stock, $0.01 par value (CVRX)
CUSIP: 126638105
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 170,072
- Total 13F value
- $877,113
- Share change
- +78,182
- SEC-reported price per share
- $5.14
- Number of holders
- 19
- Value change
- +$354,445
- Number of buys
- 7
- Number of sells
- 9
- Shares outstanding
- 26,135,461
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
19
Top holders
10
CVRX full security history
Ownership snapshot
Full 13F holder table
CVRx, Inc. SEC filings
CVRx, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 126638105
Recent filing periods:
Ownership snapshot
Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JOHNSON & JOHNSON
Disclosed value leader
JOHNSON & JOHNSON
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 15%
13D/G row: JOHNSON & JOHNSON
Showing 1-6 of 15 holder rows.
Quick read
JOHNSON & JOHNSON leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JOHNSON & JOHNSON's linked filing trail.
Comparable ownership
Top 5
JOHNSON & JOHNSON
15%
NEW ENTERPRISE ASSOCIATES 10 L P
7.8%
Vensana Capital I GP, LLC
7.2%
Gilde Healthcare IV U.a. Cooperat...
4.9%
NEA Management Company, LLC
7.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON |
3/4/5
13D/G
13F
10%+ Owner · Company
|
15%
from 13D/G
|
$40,369,355
4,024,861 shares
|
-$861,042 | 26 Nov 2025 |
| NEW ENTERPRISE ASSOCIATES 10 L P |
3/4/5
13D/G
10%+ Owner · New Enterprise Associates 10, Limited Partnership
|
7.8%
from 13D/G
|
$37,593,767
2,026,083 shares
|
— | 02 Jul 2021 |
| Vensana Capital I GP, LLC |
13D/G
Kirk Nielsen
|
7.2%
|
$11,849,740
1,760,734 shares
|
$0 | 31 Dec 2024 |
| Gilde Healthcare IV U.a. Cooperatieve |
13D/G
Cooperatieve Gilde Healthcare IV U.A.
|
4.9%
|
$8,287,928
1,231,490 shares
|
$0 | 04 Feb 2025 |
| NEA Management Company, LLC |
13F
Company
|
7.8%
|
$19,166,745
2,026,083 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
3.9%
|
$9,711,248
1,026,559 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
170,072
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
98
Q2 2026 holders
19
Holder diff
-79
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend